Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization

American Journal of Pathology

Volumn 153, Issue 4, 1998, Pages 1089-1098

  Walch, Axel K ^a   Zitzelsberger, Horst F ^a   Aubele, Michaela M ^a   Mattis, Anita E ^b   Bauchinger, Manfred ^a   Candidus, Sonja ^b   Präuer, Heinz W ^c   Werner, Martin ^b   Höfler, Heinz ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOID; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOME; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYBRIDIZATION; LARGE CELL CARCINOMA; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL;

EID: 0031715336     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65653-2     Document Type: Article

References (54)

1. Bensch KG, Corrin B, Pariente R, Spencer H: Oat-cell carcinoma of the lung: its origin and relationship to bronchial carcinoid. Cancer 1968, 22:1163-1172
2. Arrigoni MG, Woolner LB, Bernatz PE: Atypical carcinoid tumors of the lung. J Thorac Carciovasc Surg 1972, 64:413-421
3. Gould VER, Linnoila I, Memoli VA, Warren WH: Neuroendocrine cells and neuroendocrine neoplasms of the lung. Lab Invest 1983, 49:519-539
4. Warren WH, Memoli VA, Gould VE: Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. I. Carcinoids. Ultrastruct Pathol 1984, 6:15-27
5. Warren WH, Memoli VA, Gould VE: Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. II. Well-differentiated neuroendocrine carcinomas. Ultrastruct Pathol 1984, 7:185-199
6. Warren WH, Memoli VA, Gould VE: Well differentiated and small cell neuroendocrine carcinomas of the lung: two related but distinct clinicopathologic entities. Virchows Arch B 1988, 55:299-310
7. Warren EW Jr, Faber LP, Gould VE: Neuroendocrine neoplasms of the lung: a clinicopathologic update. J Thorac Carciovasc Surg 1989, 98:321-332
8. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15:529-553
9. Bonato M, Cerati M, Pagani A, Papotti M, Bosi F, Busolati G, Capella C: Differential diagnostic patterns of lung neuroendocrine tumors: a clinico-pathological and immunohistochemical study of 122 cases. Virchows Arch A 1992, 420:201-211
10. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN: Reproducibility of Neuroendocrine Lung Tumor Classification. Hum Pathol 1998, 29:272-279
11. Capella C, Heitz PU, Höfler H, Solica E, Klöppel G: Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 1995, 425:547-560
12. Levin NA, Brzoska P, Gupta N, Minna JD, Gray JW, Christman MF: Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 1994, 54:5086-5091
13. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, Du Manoir S, Cremer T: Mapping of multiple DNA gains and losses in primary small-cell lung carcinomas by comparative genomic hybridization. Cancer Res 1994, 54:1801-1806
14. Levin NA, Brzoska PM, Warnock ML, Gray JW, Christman MF: Identification of novel regions of altered DNA copy number in small cell lung tumours. Genes Chromosomes Cancer 1995, 13:175-185
15. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietl M: Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 1997, 75:79-85
16. Schwendel A, Langreck H, Reichel M, Schröck E, Ried T, Dietl M, Petersen I: Primary small-cell carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer 1997, 74:86-93
17. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD: Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14-23). Science 1982, 215:181-182
18. Testa JR, Liu Z, Feder M, Bell DW, Balsara B, Cheng JQ, Taguchi T: Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 1997, 95:20-32
19. Brennan J, O'Connor T, Makuch RW, Simmons AM, Russel E, Linnoila RI, Phelps RM, Gazdar AF, Ihde DC, Johnson BE: myc family DNA amplification in 107 tumors and tumor cell lines from patients with small-cell lung cancer treated with different combination chemotherapy regimens. Cancer Res 1991, 51:1708-1712
20. Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T, Takahashi T: Expression and amplification of myc gene family in small-cell lung cancer and its relation to biological characteristics. Cancer Res 1989, 49:2683-2688
21. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inove H, Tornielli S, Pilotti S, De Gregorio L, Pastorino V, Pierotti MA, Ohta M, Huebner K, Croce CM: The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996, 85:17-26
22. Zitzelsberger H, Lehmann L, Werner M, Bauchinger M: Comparative genomic hybridization for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem Cell Biol 1997, 108:403-417
23. Teyssier JR, Sadrin R, Nou JM, Buraeu G, Adnet JJ, Bagolle F, Pigeon F: Trisomy 7 in a lung carcinoid tumor: precocious index of malignant transformation? Cancer Genet Cytogenet 1985, 15:277-282
24. Johansson M, Heim S, Mandahl N, Hambraeus G, Johansson L, Mitelman F: Cytogenetic analysis of six bronchial carcinoids. Cancer Genet Cytogenet 1993, 66:33-38
25. Lai SL, Brauch H, Knutsen T, Johnson BE, Nau MM, Mitsudomi T, Tsai CM, Whang-Peng J, Zbar B, Kaye FJ, Gazdar AF: Molecular genetic characterization of neureoendocrine lung cancer cell lines. Anticancer Res 1995, 15:225-232
26. Lohmann DR, Fesseler B, Pütz B, Reich U, Böhm J, Präuer H, Wünsch PH, Höfler H: Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Res 1993, 53:5797-5801
27. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD: Analysis of p53, K.ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Am J Pathol 1996, 148:1531-1541
28. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL, Brambilla C: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinomas. Int J Cancer 1994, 58:818-824
29. Hurr K, Kemp B, Silver SA, EI-Naggar AK: Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Am J Pathol 1996, 149:613-620
30. Jakobovitz O, Mass D, DeMarco L, Barbosa A, Simoni FB, Rechavi G, Friedman E: Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 1996, 81: 3164-3167
31. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F: Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994, 145:1301-1308
32. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994, 10:231-243
33. duManoir S, Kallinoiemi OP, Lichter P, Piper J, Benedetti PA, Carothers AD, Fantes JA, Garcia-Sagredo JM, Gerdes T, Giollant M, Hemery B, Isola J, Maahr J, Morrison H, Perry P, Stark M, Sudar D, van Vliet LJ, Verwoerd N, Vrolijk J: Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry 1995, 19:4-9
34. Zitzelsberger H, Szücs S, Weier HU, Lehmann L, Braselmann H, Enders S, Schilling A, Breul J, Höfler H, Bauchinger M: Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue section with centromere-specific DNA probes. J Pathol 1994, 172:325-335
35. Solinas-Toldo S, Wallrapp C, Müller-Pillasch F, Bentz M, Gress T, Lichter P: Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996, 56: 3803-3807
36. Beckmann MW, Picard F, An HX, van Roeyen CR, Dominik SI, Mosny DS, Schnurch HG, Bender HG, Niederacher D: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 1996, 73:1220-1226
37. Dong Q, Delenko LV, Chandrasekharappa SC, Emmert-Buck MR, Zhuang Z, Guru SC, Manickham P, Skarulis M, Lubensky IA, Liotta LA, Collins FS, Marx SJ, Spiegel A: Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997, 82:1416-1420
38. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulmoma. Nature 1988, 332:85-87
39. Courseaux A, Grosgeorge J, Gaudray P, Pannet AAJ, Forbes SA, Williamson C, Basset D, Thakker RV, Teh BT, Farnebo F, Shepherd J, Skogseid B, Larsson C, Giraud S, Zhang CX, Salandre J, Calender A: Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. Genomics 1996, 37:354-365
40. Debelenko LV, Emmert-Buck MR, Manickham P, Guru SC, Kester MB, DiFranco EM, Olufemi SE, Agarwal S, Lubensky IA, Zhuang Z, Burns AL, Spiegel AM, Liotta LA, Collins FS, Marx SJ, Chandrasekharappa SC: Haplotype analysis defines a minimal interval for multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res 1997, 57:1039-1042
41. Emmert-Buck MR, Lubensky IA, Dong Q, Manickham P, Guru SC, Kester MB, Olufemi SE, Agarwal S, Burns AL, Spiegel AM, Collins FS, Marx SJ, Zhuang Z, Liotta LA, Chandrasekharappa SC, Debelenko LV: Localization of the multiple endocrine neoplasia type 1 (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res 1997, 57:1855-1858
42. Chandrasekharappa S, Guru S, Manickham P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree J, Wang Y, Roe B, Weisemann J, Boguski M, Agarwal S, Kester MB, Kim Y, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ: Positional cloning of the gene for multiple endocrine neoplasia 1. Science 1997, 276:404-407
43. Debeleko LV, Brambilla E, Agarwal SK, Sawlwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SG, Manickham P, Olufemi SE, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR: Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997, 13:2285-2290
44. Pfeiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, Goodfellow PJ: Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 1995, 55:1922-1926
45. Rempel SA, Schwechheimer K, Davis RL, Cavanee WK, Rosenblum ML: Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant menigioma progression. Cancer Res 1993, 53:2386-2392
46. Leenstra S, Bijlsma EK, Troost D, Oosting J, Westerveld A, Bosch DA, Hulsbos TJ: Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br J Cancer 1994, 70:684-689
47. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochnovnik EV: Mutation of the MXI1 gene in prostate cancer. Nat Genet 1995, 9:249-255
48. Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M, Yokata J: Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 1992, 7:451-457
49. Miura I, Graziano SL, Cheng JQ, Doyle A, Testa JR: Chromosome alterations in human small-cell lung cancer: frequent involvement of 5q. Cancer Res 1992, 52:1322-1328
50. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T: Loss of heterozygosity on chromosome 3, 13 and 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 1987, 84:9252-9256
51. Mori N, Yokata J, Oshima M, Cavanee WK, Mizoguchi H, Noguchi M, Shimosato Y, Sugimura T, Terada M: Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma. Cancer Res 1989, 49:5130-5135
52. Ohata M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, Mccue P, Druck T, Croce CM, Huebner K: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597
53. Godwin JD II, Brown CC: Comparative epidemiology of carcinoid and oat-cell tumors of the lung. Cancer 1977, 40:1671-1673
54. Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 1997, 79:813-829